Logo for Xenon Pharmaceuticals Inc

Xenon Pharmaceuticals Investor Relations Material

Latest events

Logo for Xenon Pharmaceuticals Inc

Q4 2024

Xenon Pharmaceuticals
Logo for Xenon Pharmaceuticals

Q4 2024

27 Feb, 2025
Logo for Xenon Pharmaceuticals

Q3 2024

12 Nov, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies

Latest reports from Xenon Pharmaceuticals Inc

Access all reports
Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapeutics for neurological disorders. The company leverages its expertise in ion channel biology to advance a pipeline of small-molecule therapies aimed at treating conditions such as epilepsy, rare neurological diseases, and other central nervous system disorders. The company is headquartered in Burnaby, Canada, and its shares are listed on the NASDAQ.